Filtered By:
Condition: Hives
Infectious Disease: SARS
This page shows you your search results in order of date.
Order by Relevance | Date
Total 122 results found since Jan 2013.
Chronic Spontaneous Urticaria Following mRNA COVID-19 Booster Vaccination at a Military Academy
We present a retrospective case series of CSU following Moderna COVID-19 booster vaccinations at the US Naval Academy (USNA). Demographics, clinical features, and impact on readiness were evaluated. Forty-nine students from the USNA were evaluated for urticaria after their third COVID-19 booster vaccination. Seventeen individuals were diagnosed with CSU. The median age was 20 years and predominantly male; the median time interval between vaccination and the onset of urticaria was 11 days. Out of 13 referred to Allergy, 7 patients had CU index performed and 2 were positive. Four patients received a second booster vaccinatio...
Source: Military Medicine - September 19, 2023 Category: International Medicine & Public Health Authors: Mechelle A Miller Emily R Raffetto Rachel U Lee Source Type: research
Characteristics of immune response profile in patients with immediate allergic and autoimmune urticarial reactions induced by SARS-CoV-2 vaccines
In conclusion, our results revealed that multiple vaccine components, inflammatory cytokines, and autoreactive IgG/IgE antibodies contribute to SARS-COV-2 vaccine-induced immediate allergic and autoimmune urticarial reactions.PMID:37245259 | PMC:PMC10183637 | DOI:10.1016/j.jaut.2023.103054
Source: Journal of Autoimmunity - May 28, 2023 Category: Allergy & Immunology Authors: Chuang-Wei Wang Chun-Bing Chen Chun-Wei Lu Wei-Ti Chen Rosaline Chung-Yee Hui Tsu-Man Chiu Min-Hui Chi Jing-Chi Lin Yu-Huei Huang Ya-Ching Chang Jennifer Wu Kuan-Yu Chen Yang Yu-Wei Lin Tzong-Yun Ger Jing Yi Lin Wan-Ting Tsai Yen-Ju Pan Wen-Hung Chung Source Type: research
Relapse or worsening of chronic spontaneous urticaria during SARS-CoV-2 infection and vaccination in children: A telemedicine follow-up
CONCLUSION: Our data showed that telemedicine can be an effective tool for the follow-up of patients with CSU. Moreover, COVID-19, as well as COVID-19 vaccination, may trigger CSU relapse or worsening, but both are unspecific triggers, and urticaria shows a very short duration in most cases.PMID:36156167 | DOI:10.15586/aei.v50iSP2.722
Source: Allergologia et Immunopathologia - September 26, 2022 Category: Allergy & Immunology Authors: Giulia Lascialfari Lucrezia Sarti Simona Barni Giulia Liccioli Erika Paladini Valentina Guarnieri Silvia Ricci Mattia Giovannini Francesca Mori Source Type: research
